Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial
J Am Coll Cardiol 2021 Mar 23;77(11)1381-1392, M Packer, SD Anker, J Butler, G Filippatos, JP Ferreira, SJ Pocock, N Sattar, M Brueckmann, W Jamal, D Cotton, T Iwata, F ZannadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.